• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性丙咪嗪治疗可降低II组代谢型谷氨酸受体的抑制特性,而不影响其密度或亲和力。

Chronic imipramine treatment reduces inhibitory properties of group II mGlu receptors without affecting their density or affinity.

作者信息

Pałucha Agnieszka, Brański Piotr, Kĺak Kinga, Sowa Magdalena

机构信息

Department of Neurobiology, Institute of Pharmacology Polish Academy of Sciences, Smetna 12, PL 31-343 Kraków, Poland.

出版信息

Pharmacol Rep. 2007 Sep-Oct;59(5):525-30.

PMID:18048952
Abstract

An increasing body of evidence indicates an important role of the glutamatergic system in the pathophysiology of depression. Not only ionotropic but also metabotropic glutamate receptors (mGlu receptors) have been suggested to be involved in the mechanism of action of antidepressant drugs. Moreover, several mGlu receptor ligands possess a great antidepressant potential. Group II mGlu receptor antagonists have been shown to induce antidepressant-like effects in rodents. An influence of chronic antidepressant treatment on group II mGlu receptors has also been suggested. In our studies, we examined an influence of repeated (21-day) imipramine treatment on the density of group II mGlu receptors and affinity of mGlu2 and mGlu3 receptor radioligand [3H]-LY341495 for group II mGlu receptors in the rat brain hippocampus and frontal cortex. Moreover, we analyzed an influence of chronic imipramine administration on the ability of group II mGlu receptor agonist, 2R,4R-APDC, to inhibit forskolin-stimulated cAMP accumulation in the rat brain cortical slices. We found that inhibitory properties of group II mGlu receptors were diminished after chronic, but not acute imipramine administration. However, no changes in the density or affinity of the mGlu2 and mGlu3 receptor ligand for group II mGlu receptors were observed.

摘要

越来越多的证据表明谷氨酸能系统在抑郁症的病理生理学中发挥重要作用。不仅离子型谷氨酸受体,而且代谢型谷氨酸受体(mGlu受体)也被认为参与了抗抑郁药物的作用机制。此外,几种mGlu受体配体具有很大的抗抑郁潜力。II组mGlu受体拮抗剂已被证明在啮齿动物中可诱导出抗抑郁样效应。也有人提出慢性抗抑郁治疗对II组mGlu受体有影响。在我们的研究中,我们检测了重复(21天)给予丙咪嗪对大鼠脑海马和额叶皮质中II组mGlu受体密度以及mGlu2和mGlu3受体放射性配体[3H]-LY341495与II组mGlu受体亲和力的影响。此外,我们分析了慢性给予丙咪嗪对II组mGlu受体激动剂2R,4R-APDC抑制大鼠脑皮质切片中福司可林刺激的cAMP积累能力的影响。我们发现,慢性而非急性给予丙咪嗪后,II组mGlu受体的抑制特性减弱。然而,未观察到mGlu2和mGlu3受体配体与II组mGlu受体的密度或亲和力发生变化。

相似文献

1
Chronic imipramine treatment reduces inhibitory properties of group II mGlu receptors without affecting their density or affinity.慢性丙咪嗪治疗可降低II组代谢型谷氨酸受体的抑制特性,而不影响其密度或亲和力。
Pharmacol Rep. 2007 Sep-Oct;59(5):525-30.
2
Regulation of phosphoinositide turnover in neonatal rat cerebral cortex by group I- and II- selective metabotropic glutamate receptor agonists.I 型和 II 型选择性代谢型谷氨酸受体激动剂对新生大鼠大脑皮层磷酸肌醇代谢的调节
Br J Pharmacol. 1998 Feb;123(3):581-9. doi: 10.1038/sj.bjp.0701626.
3
The novel metabotropic glutamate receptor agonist 2R,4R-APDC potentiates stimulation of phosphoinositide hydrolysis in the rat hippocampus by 3,5-dihydroxyphenylglycine: evidence for a synergistic interaction between group 1 and group 2 receptors.新型代谢型谷氨酸受体激动剂2R,4R-APDC增强3,5-二羟基苯甘氨酸对大鼠海马磷酸肌醇水解的刺激作用:I组和II组受体之间协同相互作用的证据。
Neuropharmacology. 1996;35(12):1661-72. doi: 10.1016/s0028-3908(96)00121-9.
4
Pharmacological profiling of native group II metabotropic glutamate receptors in primary cortical neuronal cultures using a FLIPR.使用 FLIPR 技术对原代皮质神经元培养物中的内源性 II 型代谢型谷氨酸受体进行药理学分析。
Neuropharmacology. 2013 Mar;66:264-73. doi: 10.1016/j.neuropharm.2012.05.023. Epub 2012 May 30.
5
Selective inhibition of forskolin-stimulated cyclic AMP formation in rat hippocampus by a novel mGluR agonist, 2R,4R-4-aminopyrrolidine-2,4- dicarboxylate.新型代谢型谷氨酸受体激动剂2R,4R-4-氨基吡咯烷-2,4-二羧酸对福斯高林刺激的大鼠海马中环磷酸腺苷形成的选择性抑制作用
Neuropharmacology. 1995 Aug;34(8):843-50. doi: 10.1016/0028-3908(95)00061-a.
6
Imipramine treatment up-regulates the expression and function of mGlu2/3 metabotropic glutamate receptors in the rat hippocampus.丙咪嗪治疗可上调大鼠海马中代谢型谷氨酸受体mGlu2/3的表达及功能。
Neuropharmacology. 2002 Jun;42(8):1008-15. doi: 10.1016/s0028-3908(02)00057-6.
7
Citalopram influences mGlu7, but not mGlu4 receptors' expression in the rat brain hippocampus and cortex.
Brain Res. 2007 Dec 12;1184:88-95. doi: 10.1016/j.brainres.2007.10.006. Epub 2007 Oct 13.
8
[3H]LY341495 binding to group II metabotropic glutamate receptors in rat brain.[3H]LY341495与大鼠脑内II型代谢型谷氨酸受体的结合
J Pharmacol Exp Ther. 2001 Aug;298(2):453-60.
9
Synthesis, pharmacological characterization, and molecular modeling of heterobicyclic amino acids related to (+)-2-aminobicyclo[3.1.0] hexane-2,6-dicarboxylic acid (LY354740): identification of two new potent, selective, and systemically active agonists for group II metabotropic glutamate receptors.与(+)-2-氨基双环[3.1.0]己烷-2,6-二羧酸(LY354740)相关的杂双环氨基酸的合成、药理学表征及分子模拟:两种新型强效、选择性且具有全身活性的II型代谢型谷氨酸受体激动剂的鉴定
J Med Chem. 1999 Mar 25;42(6):1027-40. doi: 10.1021/jm980616n.
10
LY341495 is a nanomolar potent and selective antagonist of group II metabotropic glutamate receptors.LY341495是一种对II型代谢型谷氨酸受体具有纳摩尔级效力和选择性的拮抗剂。
Neuropharmacology. 1998;37(1):1-12. doi: 10.1016/s0028-3908(97)00191-3.

引用本文的文献

1
Novel glutamatergic agents for major depressive disorder and bipolar disorder.新型谷氨酸能药物治疗重性抑郁障碍和双相障碍。
Pharmacol Biochem Behav. 2012 Feb;100(4):678-87. doi: 10.1016/j.pbb.2011.09.010. Epub 2011 Sep 25.
2
Targeting glutamatergic signaling for the development of novel therapeutics for mood disorders.以谷氨酸能信号传导为靶点开发情绪障碍的新型疗法。
Curr Pharm Des. 2009;15(14):1595-611. doi: 10.2174/138161209788168010.